Article archive
Published news and blog articles, organized by category. Browse older coverage by month or search for a topic. Undated blog guides appear after dated news.
325 articles · Newest first
Mental health apps effectiveness 2026: what the evidence shows and what it means
Mental-health apps can extend evidence-based support beyond the clinic, but effectiveness depends on the intervention, the user, the outcome measured, and the safeguards around care and data.
Exoskeleton rehabilitation 2026: the technology and what it means for patients
Robotic exoskeletons are turning rehabilitation into a data-rich training loop, helping some patients practice standing and walking while clinicians manage safety, fit, fatigue, and realistic goals.
AI robotic surgery 2026: the future and what it means for patients
Robotic surgery is gaining AI-assisted capabilities in planning, navigation, visualization and workflow support. The promise is more consistent precision and better information for surgeons, but patient benefit still depends on clinical…
Telemedicine and remote healthcare 2026: the state of the art and what it means
Telemedicine has moved from an emergency substitute to a durable part of healthcare delivery. Video visits, remote monitoring and connected diagnostics can expand access, but clinical quality still depends on workflow, equity, privacy and…
AI drug repurposing: the hurdles, the promise and what it means for patients
Drug repurposing searches for new uses for medicines that already have human safety information. Artificial intelligence can connect disease biology, molecular targets and clinical evidence faster, but validation, regulation, incentives…
AI for mental health diagnosis 2026: Stanford symposium and what it means
Artificial intelligence is entering mental-health research through screening, clinical decision support and digital therapeutics. A Stanford HAI symposium offers a useful lens on what these systems can detect, where their evidence remains…
CRISPR gene therapy for sickle cell: the breakthrough and what it means
CRISPR gene therapy has achieved what decades of research could not: a functional cure for sickle cell disease. The first patients treated with CRISPR-edited cells are living free of the painful crises that once defined their lives, but…
Jennifer Doudna on AI drug discovery: the promises and the reality
Jennifer Doudna, Nobel laureate for CRISPR gene editing, has turned her attention to how artificial intelligence can accelerate drug discovery. The convergence of CRISPR and AI could transform how medicines are developed, but Doudna is…
Novartis CEO on AI drug development: the impact and what it means for patients
The head of one of the world's largest pharmaceutical companies says artificial intelligence will fundamentally change how drugs are discovered, tested, and brought to market. The promise is faster, cheaper, and more targeted therapies,…
CRISPR gene editing: how it works what it can do and what comes next
CRISPR began as a microbial defense system and became a programmable gene-editing tool. Here is how Cas9 works, where therapies are arriving, and what remains uncertain.
AI breast cancer detection: how it works and what it means for patients
AI tools can flag suspicious findings in mammograms and help prioritize work for radiologists. They are decision-support systems, not autonomous diagnoses, and their value depends on clinical validation and careful workflow design.
Brain-computer interface for Parkinsons: the CES 2026 breakthrough explained
Quantum computers use superposition, interference, and entanglement to attack selected problems in a fundamentally different way, while noise and error correction still limit today’s hardware.
The new generation of brain-computer interfaces: what they can do and what is next
Humanoid robots are designed for tools and spaces made for people. This explainer covers balance, AI, leading companies, current capabilities, economic effects, and the road ahead.
Bill Gates on AI drug discovery: the transformation and what it means for health
AI is changing how researchers search chemical space, select experiments, and design clinical studies. The opportunity is large, but biology, regulation, and access still set the limits.
Jensen Huang at Recursion: how AI is enabling leaders in drug discovery
Jensen Huang's appearance at Recursion underscores how NVIDIA's AI infrastructure is reshaping pharmaceutical drug discovery — from virtual screening to clinical candidate generation.
3D-printed organs: the future of transplants and what it means for patients
3D bioprinting could revolutionize organ transplantation by creating functional organs from a patient's own cells, eliminating waiting lists and immune rejection. We examine the science, the challenges, and the timeline.
3D-printed organ transplant breakthrough: what it means and when it matters
A breakthrough in 3D bioprinting brings printed organs closer to clinical trials. Here is how the technology works, what organs are closest to trials, the bioink challenge, immune response, and what this means for patients on transplant…
AI cancer detection: reducing global disparities and what it means for patients
Artificial intelligence is transforming cancer screening by improving detection accuracy and extending diagnostic capabilities to low-resource settings. The objective of cancer screening is to detect cancer before symptoms appear. Here is…
AI therapy: the problems the risks and what actually works
AI therapy: the problems the risks and what actually works
Brain supplements 2026: the science of cognitive enhancement and what works
Brain supplements are entering 2026 with bigger claims and a mixed evidence base. This guide separates plausible mechanisms from proven effects, safety concerns, and marketing hype.
Nootropic supplements that actually work: the evidence and what you should know
Nootropic supplements promise better memory, sharper focus, and faster thinking. The peer-reviewed evidence supports some of these claims and rejects others. Here is what the research actually shows.
Brain-computer interface: how BCI gives patients independence and what it means
Brain-computer interfaces read neural signals and translate them into commands for cursors, robotic arms, and speech synthesizers, restoring agency for paralyzed patients. The technology is improving, but cost and accessibility remain the…
The future of brain-computer interfaces: what comes next and when it matters
Brain-computer interfaces are moving from the lab to human trials. Here is where the technology stands, which companies are pushing it forward, and what comes next.
Anti-aging drugs: the real science of senolytics and what they can do
Senolytic drugs selectively kill accumulated senescent cells that drive aging and chronic disease. Here is what the science actually shows about their potential and limits.
Also explore blog articles and guides or search all DutyStation pages.